 | • レポートコード：MRC2-11QY09099 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は網膜薬及び生物製剤のグローバル市場について調査・分析したレポートです。種類別（加齢性黄斑変性症、糖尿病性網膜症、眼の炎症性疾患（ブドウ膜炎）、黄斑円孔）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別網膜薬及び生物製剤の競争状況、市場シェア ・世界の網膜薬及び生物製剤市場：種類別市場規模 2015年-2020年（加齢性黄斑変性症、糖尿病性網膜症、眼の炎症性疾患（ブドウ膜炎）、黄斑円孔） ・世界の網膜薬及び生物製剤市場：種類別市場規模予測 2021年-2026年（加齢性黄斑変性症、糖尿病性網膜症、眼の炎症性疾患（ブドウ膜炎）、黄斑円孔） ・世界の網膜薬及び生物製剤市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の網膜薬及び生物製剤市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の網膜薬及び生物製剤市場分析：米国、カナダ ・ヨーロッパの網膜薬及び生物製剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの網膜薬及び生物製剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の網膜薬及び生物製剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの網膜薬及び生物製剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：ALLERGAN、AbbVie、Alimera Sciences、Janssen Biotech、Swedish Orphan Biovitrum、Roche、Bristol-Myers Squibb、Genzyme、Genentech、OCULAR THERAPEUTIX、Bausch & Lomb、UCBCares ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A biologic is manufactured in a living system such as a microorganism, or plant or animal cells. Most biologics are very large, complex molecules or mixtures of molecules. Many biologics are produced using recombinant DNA technology.
Global Retinal Drugs and Biologics market is highly fragmented with the presence of multiple players.
Market Analysis and Insights: Global Retinal Drugs and Biologics Market
The global Retinal Drugs and Biologics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Retinal Drugs and Biologics Scope and Market Size
Retinal Drugs and Biologics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Drugs and Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Retinal Drugs and Biologics market is segmented into
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
Segment by Application, the Retinal Drugs and Biologics market is segmented into
Hospitals
Clinics
Others
Regional and Country-level Analysis
The Retinal Drugs and Biologics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Retinal Drugs and Biologics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Retinal Drugs and Biologics Market Share Analysis
Retinal Drugs and Biologics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Retinal Drugs and Biologics business, the date to enter into the Retinal Drugs and Biologics market, Retinal Drugs and Biologics product introduction, recent developments, etc.
The major vendors covered:
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
1 Study Coverage
1.1 Retinal Drugs and Biologics Product Introduction
1.2 Market Segments
1.3 Key Retinal Drugs and Biologics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Retinal Drugs and Biologics Market Size Growth Rate by Type
1.4.2 Age Related Macular Degeneration
1.4.3 Diabetic Retinopathy
1.4.4 Ocular Inflammatory Disease (Uveitis)
1.4.5 Macular Hole
1.5 Market by Application
1.5.1 Global Retinal Drugs and Biologics Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Retinal Drugs and Biologics Market Size, Estimates and Forecasts
2.1.1 Global Retinal Drugs and Biologics Revenue 2015-2026
2.1.2 Global Retinal Drugs and Biologics Sales 2015-2026
2.2 Global Retinal Drugs and Biologics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Retinal Drugs and Biologics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Retinal Drugs and Biologics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Retinal Drugs and Biologics Competitor Landscape by Players
3.1 Retinal Drugs and Biologics Sales by Manufacturers
3.1.1 Retinal Drugs and Biologics Sales by Manufacturers (2015-2020)
3.1.2 Retinal Drugs and Biologics Sales Market Share by Manufacturers (2015-2020)
3.2 Retinal Drugs and Biologics Revenue by Manufacturers
3.2.1 Retinal Drugs and Biologics Revenue by Manufacturers (2015-2020)
3.2.2 Retinal Drugs and Biologics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Retinal Drugs and Biologics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Retinal Drugs and Biologics Revenue in 2019
3.2.5 Global Retinal Drugs and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Retinal Drugs and Biologics Price by Manufacturers
3.4 Retinal Drugs and Biologics Manufacturing Base Distribution, Product Types
3.4.1 Retinal Drugs and Biologics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Retinal Drugs and Biologics Product Type
3.4.3 Date of International Manufacturers Enter into Retinal Drugs and Biologics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Retinal Drugs and Biologics Market Size by Type (2015-2020)
4.1.1 Global Retinal Drugs and Biologics Sales by Type (2015-2020)
4.1.2 Global Retinal Drugs and Biologics Revenue by Type (2015-2020)
4.1.3 Retinal Drugs and Biologics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Retinal Drugs and Biologics Market Size Forecast by Type (2021-2026)
4.2.1 Global Retinal Drugs and Biologics Sales Forecast by Type (2021-2026)
4.2.2 Global Retinal Drugs and Biologics Revenue Forecast by Type (2021-2026)
4.2.3 Retinal Drugs and Biologics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Retinal Drugs and Biologics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Retinal Drugs and Biologics Market Size by Application (2015-2020)
5.1.1 Global Retinal Drugs and Biologics Sales by Application (2015-2020)
5.1.2 Global Retinal Drugs and Biologics Revenue by Application (2015-2020)
5.1.3 Retinal Drugs and Biologics Price by Application (2015-2020)
5.2 Retinal Drugs and Biologics Market Size Forecast by Application (2021-2026)
5.2.1 Global Retinal Drugs and Biologics Sales Forecast by Application (2021-2026)
5.2.2 Global Retinal Drugs and Biologics Revenue Forecast by Application (2021-2026)
5.2.3 Global Retinal Drugs and Biologics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Retinal Drugs and Biologics by Country
6.1.1 North America Retinal Drugs and Biologics Sales by Country
6.1.2 North America Retinal Drugs and Biologics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Retinal Drugs and Biologics Market Facts & Figures by Type
6.3 North America Retinal Drugs and Biologics Market Facts & Figures by Application
7 Europe
7.1 Europe Retinal Drugs and Biologics by Country
7.1.1 Europe Retinal Drugs and Biologics Sales by Country
7.1.2 Europe Retinal Drugs and Biologics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Retinal Drugs and Biologics Market Facts & Figures by Type
7.3 Europe Retinal Drugs and Biologics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Retinal Drugs and Biologics by Region
8.1.1 Asia Pacific Retinal Drugs and Biologics Sales by Region
8.1.2 Asia Pacific Retinal Drugs and Biologics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Retinal Drugs and Biologics Market Facts & Figures by Type
8.3 Asia Pacific Retinal Drugs and Biologics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Retinal Drugs and Biologics by Country
9.1.1 Latin America Retinal Drugs and Biologics Sales by Country
9.1.2 Latin America Retinal Drugs and Biologics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Retinal Drugs and Biologics Market Facts & Figures by Type
9.3 Central & South America Retinal Drugs and Biologics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Retinal Drugs and Biologics by Country
10.1.1 Middle East and Africa Retinal Drugs and Biologics Sales by Country
10.1.2 Middle East and Africa Retinal Drugs and Biologics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Retinal Drugs and Biologics Market Facts & Figures by Type
10.3 Middle East and Africa Retinal Drugs and Biologics Market Facts & Figures by Application
11 Company Profiles
11.1 ALLERGAN
11.1.1 ALLERGAN Corporation Information
11.1.2 ALLERGAN Description and Business Overview
11.1.3 ALLERGAN Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ALLERGAN Retinal Drugs and Biologics Products Offered
11.1.5 ALLERGAN Related Developments
11.2 AbbVie
11.2.1 AbbVie Corporation Information
11.2.2 AbbVie Description and Business Overview
11.2.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AbbVie Retinal Drugs and Biologics Products Offered
11.2.5 AbbVie Related Developments
11.3 Alimera Sciences
11.3.1 Alimera Sciences Corporation Information
11.3.2 Alimera Sciences Description and Business Overview
11.3.3 Alimera Sciences Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Alimera Sciences Retinal Drugs and Biologics Products Offered
11.3.5 Alimera Sciences Related Developments
11.4 Janssen Biotech
11.4.1 Janssen Biotech Corporation Information
11.4.2 Janssen Biotech Description and Business Overview
11.4.3 Janssen Biotech Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Janssen Biotech Retinal Drugs and Biologics Products Offered
11.4.5 Janssen Biotech Related Developments
11.5 Swedish Orphan Biovitrum
11.5.1 Swedish Orphan Biovitrum Corporation Information
11.5.2 Swedish Orphan Biovitrum Description and Business Overview
11.5.3 Swedish Orphan Biovitrum Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Products Offered
11.5.5 Swedish Orphan Biovitrum Related Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Description and Business Overview
11.6.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Roche Retinal Drugs and Biologics Products Offered
11.6.5 Roche Related Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Corporation Information
11.7.2 Bristol-Myers Squibb Description and Business Overview
11.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bristol-Myers Squibb Retinal Drugs and Biologics Products Offered
11.7.5 Bristol-Myers Squibb Related Developments
11.8 Genzyme
11.8.1 Genzyme Corporation Information
11.8.2 Genzyme Description and Business Overview
11.8.3 Genzyme Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Genzyme Retinal Drugs and Biologics Products Offered
11.8.5 Genzyme Related Developments
11.9 Genentech
11.9.1 Genentech Corporation Information
11.9.2 Genentech Description and Business Overview
11.9.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Genentech Retinal Drugs and Biologics Products Offered
11.9.5 Genentech Related Developments
11.10 OCULAR THERAPEUTIX
11.10.1 OCULAR THERAPEUTIX Corporation Information
11.10.2 OCULAR THERAPEUTIX Description and Business Overview
11.10.3 OCULAR THERAPEUTIX Sales, Revenue and Gross Margin (2015-2020)
11.10.4 OCULAR THERAPEUTIX Retinal Drugs and Biologics Products Offered
11.10.5 OCULAR THERAPEUTIX Related Developments
11.1 ALLERGAN
11.1.1 ALLERGAN Corporation Information
11.1.2 ALLERGAN Description and Business Overview
11.1.3 ALLERGAN Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ALLERGAN Retinal Drugs and Biologics Products Offered
11.1.5 ALLERGAN Related Developments
11.12 UCBCares
11.12.1 UCBCares Corporation Information
11.12.2 UCBCares Description and Business Overview
11.12.3 UCBCares Sales, Revenue and Gross Margin (2015-2020)
11.12.4 UCBCares Products Offered
11.12.5 UCBCares Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Retinal Drugs and Biologics Market Estimates and Projections by Region
12.1.1 Global Retinal Drugs and Biologics Sales Forecast by Regions 2021-2026
12.1.2 Global Retinal Drugs and Biologics Revenue Forecast by Regions 2021-2026
12.2 North America Retinal Drugs and Biologics Market Size Forecast (2021-2026)
12.2.1 North America: Retinal Drugs and Biologics Sales Forecast (2021-2026)
12.2.2 North America: Retinal Drugs and Biologics Revenue Forecast (2021-2026)
12.2.3 North America: Retinal Drugs and Biologics Market Size Forecast by Country (2021-2026)
12.3 Europe Retinal Drugs and Biologics Market Size Forecast (2021-2026)
12.3.1 Europe: Retinal Drugs and Biologics Sales Forecast (2021-2026)
12.3.2 Europe: Retinal Drugs and Biologics Revenue Forecast (2021-2026)
12.3.3 Europe: Retinal Drugs and Biologics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Retinal Drugs and Biologics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Retinal Drugs and Biologics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Retinal Drugs and Biologics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Retinal Drugs and Biologics Market Size Forecast by Region (2021-2026)
12.5 Latin America Retinal Drugs and Biologics Market Size Forecast (2021-2026)
12.5.1 Latin America: Retinal Drugs and Biologics Sales Forecast (2021-2026)
12.5.2 Latin America: Retinal Drugs and Biologics Revenue Forecast (2021-2026)
12.5.3 Latin America: Retinal Drugs and Biologics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Retinal Drugs and Biologics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Retinal Drugs and Biologics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Retinal Drugs and Biologics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Retinal Drugs and Biologics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Retinal Drugs and Biologics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Retinal Drugs and Biologics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Retinal Drugs and Biologics Market Segments
Table 2. Ranking of Global Top Retinal Drugs and Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Retinal Drugs and Biologics Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Age Related Macular Degeneration
Table 5. Major Manufacturers of Diabetic Retinopathy
Table 6. Major Manufacturers of Ocular Inflammatory Disease (Uveitis)
Table 7. Major Manufacturers of Macular Hole
Table 8. Global Retinal Drugs and Biologics Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Retinal Drugs and Biologics Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Retinal Drugs and Biologics Sales by Regions 2015-2020 (K MT)
Table 11. Global Retinal Drugs and Biologics Sales Market Share by Regions (2015-2020)
Table 12. Global Retinal Drugs and Biologics Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Retinal Drugs and Biologics Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Retinal Drugs and Biologics Sales Share by Manufacturers (2015-2020)
Table 15. Global Retinal Drugs and Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Retinal Drugs and Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Drugs and Biologics as of 2019)
Table 17. Retinal Drugs and Biologics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Retinal Drugs and Biologics Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Retinal Drugs and Biologics Price (2015-2020) (USD/MT)
Table 20. Retinal Drugs and Biologics Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Retinal Drugs and Biologics Product Type
Table 22. Date of International Manufacturers Enter into Retinal Drugs and Biologics Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Retinal Drugs and Biologics Sales by Type (2015-2020) (K MT)
Table 25. Global Retinal Drugs and Biologics Sales Share by Type (2015-2020)
Table 26. Global Retinal Drugs and Biologics Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Retinal Drugs and Biologics Revenue Share by Type (2015-2020)
Table 28. Retinal Drugs and Biologics Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Retinal Drugs and Biologics Sales by Application (2015-2020) (K MT)
Table 30. Global Retinal Drugs and Biologics Sales Share by Application (2015-2020)
Table 31. North America Retinal Drugs and Biologics Sales by Country (2015-2020) (K MT)
Table 32. North America Retinal Drugs and Biologics Sales Market Share by Country (2015-2020)
Table 33. North America Retinal Drugs and Biologics Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Retinal Drugs and Biologics Revenue Market Share by Country (2015-2020)
Table 35. North America Retinal Drugs and Biologics Sales by Type (2015-2020) (K MT)
Table 36. North America Retinal Drugs and Biologics Sales Market Share by Type (2015-2020)
Table 37. North America Retinal Drugs and Biologics Sales by Application (2015-2020) (K MT)
Table 38. North America Retinal Drugs and Biologics Sales Market Share by Application (2015-2020)
Table 39. Europe Retinal Drugs and Biologics Sales by Country (2015-2020) (K MT)
Table 40. Europe Retinal Drugs and Biologics Sales Market Share by Country (2015-2020)
Table 41. Europe Retinal Drugs and Biologics Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Retinal Drugs and Biologics Revenue Market Share by Country (2015-2020)
Table 43. Europe Retinal Drugs and Biologics Sales by Type (2015-2020) (K MT)
Table 44. Europe Retinal Drugs and Biologics Sales Market Share by Type (2015-2020)
Table 45. Europe Retinal Drugs and Biologics Sales by Application (2015-2020) (K MT)
Table 46. Europe Retinal Drugs and Biologics Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Retinal Drugs and Biologics Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Retinal Drugs and Biologics Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Retinal Drugs and Biologics Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Retinal Drugs and Biologics Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Retinal Drugs and Biologics Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Retinal Drugs and Biologics Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Retinal Drugs and Biologics Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Retinal Drugs and Biologics Sales Market Share by Application (2015-2020)
Table 55. Latin America Retinal Drugs and Biologics Sales by Country (2015-2020) (K MT)
Table 56. Latin America Retinal Drugs and Biologics Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Retinal Drugs and Biologics Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Retinal Drugs and Biologics Revenue Market Share by Country (2015-2020)
Table 59. Latin America Retinal Drugs and Biologics Sales by Type (2015-2020) (K MT)
Table 60. Latin America Retinal Drugs and Biologics Sales Market Share by Type (2015-2020)
Table 61. Latin America Retinal Drugs and Biologics Sales by Application (2015-2020) (K MT)
Table 62. Latin America Retinal Drugs and Biologics Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Retinal Drugs and Biologics Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Retinal Drugs and Biologics Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Retinal Drugs and Biologics Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Retinal Drugs and Biologics Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Retinal Drugs and Biologics Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Retinal Drugs and Biologics Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Retinal Drugs and Biologics Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Retinal Drugs and Biologics Sales Market Share by Application (2015-2020)
Table 71. ALLERGAN Corporation Information
Table 72. ALLERGAN Description and Major Businesses
Table 73. ALLERGAN Retinal Drugs and Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. ALLERGAN Product
Table 75. ALLERGAN Recent Development
Table 76. AbbVie Corporation Information
Table 77. AbbVie Description and Major Businesses
Table 78. AbbVie Retinal Drugs and Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. AbbVie Product
Table 80. AbbVie Recent Development
Table 81. Alimera Sciences Corporation Information
Table 82. Alimera Sciences Description and Major Businesses
Table 83. Alimera Sciences Retinal Drugs and Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Alimera Sciences Product
Table 85. Alimera Sciences Recent Development
Table 86. Janssen Biotech Corporation Information
Table 87. Janssen Biotech Description and Major Businesses
Table 88. Janssen Biotech Retinal Drugs and Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Janssen Biotech Product
Table 90. Janssen Biotech Recent Development
Table 91. Swedish Orphan Biovitrum Corporation Information
Table 92. Swedish Orphan Biovitrum Description and Major Businesses
Table 93. Swedish Orphan Biovitrum Retinal Drugs and Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Swedish Orphan Biovitrum Product
Table 95. Swedish Orphan Biovitrum Recent Development
Table 96. Roche Corporation Information
Table 97. Roche Description and Major Businesses
Table 98. Roche Retinal Drugs and Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Roche Product
Table 100. Roche Recent Development
Table 101. Bristol-Myers Squibb Corporation Information
Table 102. Bristol-Myers Squibb Description and Major Businesses
Table 103. Bristol-Myers Squibb Retinal Drugs and Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Bristol-Myers Squibb Product
Table 105. Bristol-Myers Squibb Recent Development
Table 106. Genzyme Corporation Information
Table 107. Genzyme Description and Major Businesses
Table 108. Genzyme Retinal Drugs and Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Genzyme Product
Table 110. Genzyme Recent Development
Table 111. Genentech Corporation Information
Table 112. Genentech Description and Major Businesses
Table 113. Genentech Retinal Drugs and Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Genentech Product
Table 115. Genentech Recent Development
Table 116. OCULAR THERAPEUTIX Corporation Information
Table 117. OCULAR THERAPEUTIX Description and Major Businesses
Table 118. OCULAR THERAPEUTIX Retinal Drugs and Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. OCULAR THERAPEUTIX Product
Table 120. OCULAR THERAPEUTIX Recent Development
Table 121. Bausch & Lomb Corporation Information
Table 122. Bausch & Lomb Description and Major Businesses
Table 123. Bausch & Lomb Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Bausch & Lomb Product
Table 125. Bausch & Lomb Recent Development
Table 126. UCBCares Corporation Information
Table 127. UCBCares Description and Major Businesses
Table 128. UCBCares Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. UCBCares Product
Table 130. UCBCares Recent Development
Table 131. Global Retinal Drugs and Biologics Sales Forecast by Regions (2021-2026) (K MT)
Table 132. Global Retinal Drugs and Biologics Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Retinal Drugs and Biologics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Retinal Drugs and Biologics Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Retinal Drugs and Biologics Sales Forecast by Country (2021-2026) (K MT)
Table 136. North America: Retinal Drugs and Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Retinal Drugs and Biologics Sales Forecast by Country (2021-2026) (K MT)
Table 138. Europe: Retinal Drugs and Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Retinal Drugs and Biologics Sales Forecast by Region (2021-2026) (K MT)
Table 140. Asia Pacific: Retinal Drugs and Biologics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Retinal Drugs and Biologics Sales Forecast by Country (2021-2026) (K MT)
Table 142. Latin America: Retinal Drugs and Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Retinal Drugs and Biologics Sales Forecast by Country (2021-2026) (K MT)
Table 144. Middle East and Africa: Retinal Drugs and Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Retinal Drugs and Biologics Players
Table 149. Retinal Drugs and Biologics Customers List
Table 150. Retinal Drugs and Biologics Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Retinal Drugs and Biologics Product Picture
Figure 2. Global Retinal Drugs and Biologics Sales Market Share by Type in 2020 & 2026
Figure 3. Age Related Macular Degeneration Product Picture
Figure 4. Diabetic Retinopathy Product Picture
Figure 5. Ocular Inflammatory Disease (Uveitis) Product Picture
Figure 6. Macular Hole Product Picture
Figure 7. Global Retinal Drugs and Biologics Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Retinal Drugs and Biologics Report Years Considered
Figure 12. Global Retinal Drugs and Biologics Market Size 2015-2026 (US$ Million)
Figure 13. Global Retinal Drugs and Biologics Sales 2015-2026 (K MT)
Figure 14. Global Retinal Drugs and Biologics Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Retinal Drugs and Biologics Sales Market Share by Region (2015-2020)
Figure 16. Global Retinal Drugs and Biologics Sales Market Share by Region in 2019
Figure 17. Global Retinal Drugs and Biologics Revenue Market Share by Region (2015-2020)
Figure 18. Global Retinal Drugs and Biologics Revenue Market Share by Region in 2019
Figure 19. Global Retinal Drugs and Biologics Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Retinal Drugs and Biologics Revenue in 2019
Figure 21. Retinal Drugs and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Retinal Drugs and Biologics Sales Market Share by Type (2015-2020)
Figure 23. Global Retinal Drugs and Biologics Sales Market Share by Type in 2019
Figure 24. Global Retinal Drugs and Biologics Revenue Market Share by Type (2015-2020)
Figure 25. Global Retinal Drugs and Biologics Revenue Market Share by Type in 2019
Figure 26. Global Retinal Drugs and Biologics Market Share by Price Range (2015-2020)
Figure 27. Global Retinal Drugs and Biologics Sales Market Share by Application (2015-2020)
Figure 28. Global Retinal Drugs and Biologics Sales Market Share by Application in 2019
Figure 29. Global Retinal Drugs and Biologics Revenue Market Share by Application (2015-2020)
Figure 30. Global Retinal Drugs and Biologics Revenue Market Share by Application in 2019
Figure 31. North America Retinal Drugs and Biologics Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Retinal Drugs and Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Retinal Drugs and Biologics Sales Market Share by Country in 2019
Figure 34. North America Retinal Drugs and Biologics Revenue Market Share by Country in 2019
Figure 35. U.S. Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Retinal Drugs and Biologics Market Share by Type in 2019
Figure 40. North America Retinal Drugs and Biologics Market Share by Application in 2019
Figure 41. Europe Retinal Drugs and Biologics Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Retinal Drugs and Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Retinal Drugs and Biologics Sales Market Share by Country in 2019
Figure 44. Europe Retinal Drugs and Biologics Revenue Market Share by Country in 2019
Figure 45. Germany Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Retinal Drugs and Biologics Market Share by Type in 2019
Figure 56. Europe Retinal Drugs and Biologics Market Share by Application in 2019
Figure 57. Asia Pacific Retinal Drugs and Biologics Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Retinal Drugs and Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Retinal Drugs and Biologics Sales Market Share by Region in 2019
Figure 60. Asia Pacific Retinal Drugs and Biologics Revenue Market Share by Region in 2019
Figure 61. China Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Retinal Drugs and Biologics Market Share by Type in 2019
Figure 84. Asia Pacific Retinal Drugs and Biologics Market Share by Application in 2019
Figure 85. Latin America Retinal Drugs and Biologics Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Retinal Drugs and Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Retinal Drugs and Biologics Sales Market Share by Country in 2019
Figure 88. Latin America Retinal Drugs and Biologics Revenue Market Share by Country in 2019
Figure 89. Mexico Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Retinal Drugs and Biologics Market Share by Type in 2019
Figure 96. Latin America Retinal Drugs and Biologics Market Share by Application in 2019
Figure 97. Middle East and Africa Retinal Drugs and Biologics Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Retinal Drugs and Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Retinal Drugs and Biologics Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Retinal Drugs and Biologics Revenue Market Share by Country in 2019
Figure 101. Turkey Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Retinal Drugs and Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Retinal Drugs and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Retinal Drugs and Biologics Market Share by Type in 2019
Figure 108. Middle East and Africa Retinal Drugs and Biologics Market Share by Application in 2019
Figure 109. North America Retinal Drugs and Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Retinal Drugs and Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Retinal Drugs and Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Retinal Drugs and Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Retinal Drugs and Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Retinal Drugs and Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Retinal Drugs and Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Retinal Drugs and Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Retinal Drugs and Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Retinal Drugs and Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
黄斑変性症（AMD）・糖尿病性網膜症（DR）治療薬の世界市場（～2026年） Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…- 黄斑変性症（AMD）の世界市場（～2026年） Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. The North American region is the most lucrative market, ow…
- 網膜静脈閉塞症治療薬の世界市場（～2026年） Retinal vein occlusion (RVO) is a sight-threatening retinal vascular disorder associated with macular edema and neovascularization. The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CR…
- 糖尿病網膜症（DR）治療薬の世界市場（～2026年） Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes. The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising…
- 網膜剥離の世界市場（～2026年） Retinal detachment occurs when the light-sensitive membrane (retina) in the back of the eye separates from its supporting layers. Most of the retinal detachments occurs due to retinal break, tear or hole. Retinal detachment can cause partial or total blindness, depending upon how much of the retina …